APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ibuprofen

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.

Selected research

Market Outlook & Growth Opportunities

Global Ibuprofen Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchIbuprofen Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Ibuprofen Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Ibuprofen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ibuprofen Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ibuprofen Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.

Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, with about 81% market shares.

China is the largest supplier of Ibuprofen, with a production market share nearly 48%. India is the second largest supplier of Ibuprofen, enjoying production market share nearly 30%.

Read the full market overview

North America is the largest sales place, with a sales market share nearly 29%. Following North America, Europe is the second largest sales place with the sales market share of 26%.

The classification of Ibuprofen includes USP and EP and the sales proportion of USP Ibuprofen is about 65%.

Ibuprofen is applied in Tablet, Capsule, Suspension and Other. The most proportion of Ibuprofen is used in Tablet, and the market share is about 46%.

This report provides an overview of the global Ibuprofen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ibuprofen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ibuprofen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ibuprofen market size, projected growth trends, production technologies, key applications, and end-use industries.

Ibuprofen Segment by Company

Xinhua Pharmaceutical

IOLCP

Granules Biocause

Strides Shasun

BASF

SI Group

Xinhua-Perrigo Pharmaceutical

Hisoar

Ibuprofen Segment by Type

USP

EP

Ibuprofen Segment by Application

Tablet

Capsule

Suspension

Others

Ibuprofen Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ibuprofen status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ibuprofen market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ibuprofen significant trends, drivers, influence factors in global and regions.

6. To analyze Ibuprofen competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ibuprofen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ibuprofen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ibuprofen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ibuprofen market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ibuprofen industry.

Chapter 3: Detailed analysis of Ibuprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ibuprofen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ibuprofen in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ibuprofen Industry Trends Table 2. Ibuprofen Industry Drivers Table 3. Ibuprofen Industry Opportunities and Challenges Table 4. Ibuprofen Industry Restraints Table 5. Global Ibuprofen Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ibuprofen Revenue Share by Company (2021-2026) Table 7. Global Ibuprofen Sales Volume by Company (t) & (2021-2026) Table 8. Global Ibuprofen Sales Volume Share by Company (2021-2026) Table 9. Global Ibuprofen Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Ibuprofen Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ibuprofen Key Company Manufacturing Base & Headquarters Table 12. Global Ibuprofen Company, Product Type & Application Table 13. Global Ibuprofen Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ibuprofen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of USP Table 18. Significant Companies of EP Table 19. Global Ibuprofen Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Ibuprofen Sales Volume by Type (2021-2026) & (t) Table 21. Global Ibuprofen Sales Volume by Type (2027-2032) & (t) Table 22. Global Ibuprofen Sales Volume Share by Type (2021-2026) Table 23. Global Ibuprofen Sales Volume Share by Type (2027-2032) Table 24. Global Ibuprofen Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ibuprofen Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ibuprofen Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ibuprofen Sales Value Share by Type (2021-2026) Table 28. Global Ibuprofen Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Tablet Table 30. Significant Companies of Capsule Table 31. Significant Companies of Suspension Table 32. Significant Companies of Others Table 33. Global Ibuprofen Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Ibuprofen Sales Volume by Application (2021-2026) & (t) Table 35. Global Ibuprofen Sales Volume by Application (2027-2032) & (t) Table 36. Global Ibuprofen Sales Volume Share by Application (2021-2026) Table 37. Global Ibuprofen Sales Volume Share by Application (2027-2032) Table 38. Global Ibuprofen Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Ibuprofen Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Ibuprofen Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Ibuprofen Sales Value Share by Application (2021-2026) Table 42. Global Ibuprofen Sales Value Share by Application (2027-2032) Table 43. Global Ibuprofen Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Ibuprofen Sales by Region (2021-2026) & (t) Table 45. Global Ibuprofen Sales Market Share by Region (2021-2026) Table 46. Global Ibuprofen Sales by Region (2027-2032) & (t) Table 47. Global Ibuprofen Sales Market Share by Region (2027-2032) Table 48. Global Ibuprofen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Ibuprofen Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Ibuprofen Sales Value Share by Region (2021-2026) Table 51. Global Ibuprofen Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Ibuprofen Sales Value Share by Region (2027-2032) Table 53. Global Ibuprofen Market Average Price (USD/Kg) by Region (2021-2026) Table 54. Global Ibuprofen Market Average Price (USD/Kg) by Region (2027-2032) Table 55. Global Ibuprofen Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Ibuprofen Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Ibuprofen Sales by Country (2021-2026) & (t) Table 58. Global Ibuprofen Sales Market Share by Country (2021-2026) Table 59. Global Ibuprofen Sales by Country (2027-2032) & (t) Table 60. Global Ibuprofen Sales Market Share by Country (2027-2032) Table 61. Global Ibuprofen Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Ibuprofen Sales Value Market Share by Country (2021-2026) Table 63. Global Ibuprofen Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Ibuprofen Sales Value Market Share by Country (2027-2032) Table 65. Xinhua Pharmaceutical Company Information Table 66. Xinhua Pharmaceutical Business Overview Table 67. Xinhua Pharmaceutical Ibuprofen Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 68. Xinhua Pharmaceutical Ibuprofen Product Portfolio Table 69. Xinhua Pharmaceutical Recent Development Table 70. IOLCP Company Information Table 71. IOLCP Business Overview Table 72. IOLCP Ibuprofen Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 73. IOLCP Ibuprofen Product Portfolio Table 74. IOLCP Recent Development Table 75. Granules Biocause Company Information Table 76. Granules Biocause Business Overview Table 77. Granules Biocause Ibuprofen Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 78. Granules Biocause Ibuprofen Product Portfolio Table 79. Granules Biocause Recent Development Table 80. Strides Shasun Company Information Table 81. Strides Shasun Business Overview Table 82. Strides Shasun Ibuprofen Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 83. Strides Shasun Ibuprofen Product Portfolio Table 84. Strides Shasun Recent Development Table 85. BASF Company Information Table 86. BASF Business Overview Table 87. BASF Ibuprofen Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 88. BASF Ibuprofen Product Portfolio Table 89. BASF Recent Development Table 90. SI Group Company Information Table 91. SI Group Business Overview Table 92. SI Group Ibuprofen Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 93. SI Group Ibuprofen Product Portfolio Table 94. SI Group Recent Development Table 95. Xinhua-Perrigo Pharmaceutical Company Information Table 96. Xinhua-Perrigo Pharmaceutical Business Overview Table 97. Xinhua-Perrigo Pharmaceutical Ibuprofen Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 98. Xinhua-Perrigo Pharmaceutical Ibuprofen Product Portfolio Table 99. Xinhua-Perrigo Pharmaceutical Recent Development Table 100. Hisoar Company Information Table 101. Hisoar Business Overview Table 102. Hisoar Ibuprofen Sales (t), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 103. Hisoar Ibuprofen Product Portfolio Table 104. Hisoar Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Ibuprofen Distributors List Table 108. Ibuprofen Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Ibuprofen Product Image Figure 2. Global Ibuprofen Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ibuprofen Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ibuprofen Sales (2021-2032) & (t) Figure 5. Global Ibuprofen Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Ibuprofen Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. USP Image Figure 10. EP Image Figure 11. Global Ibuprofen Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Ibuprofen Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ibuprofen Sales Volume Share by Type (2021-2032) Figure 14. Global Ibuprofen Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ibuprofen Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ibuprofen Sales Value Share by Type (2021-2032) Figure 17. Tablet Image Figure 18. Capsule Image Figure 19. Suspension Image Figure 20. Others Image Figure 21. Global Ibuprofen Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Ibuprofen Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Ibuprofen Sales Volume Share by Application (2021-2032) Figure 24. Global Ibuprofen Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Ibuprofen Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Ibuprofen Sales Value Share by Application (2021-2032) Figure 27. Global Ibuprofen Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Ibuprofen Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Ibuprofen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Ibuprofen Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Ibuprofen Sales Value (2021-2032) & (US$ Million) Figure 32. North America Ibuprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Ibuprofen Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Ibuprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Ibuprofen Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Ibuprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Ibuprofen Sales Value (2021-2032) & (US$ Million) Figure 38. South America Ibuprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Ibuprofen Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Ibuprofen Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Ibuprofen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Ibuprofen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Ibuprofen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Ibuprofen Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Ibuprofen Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • USP
  • EP
Applications
  • Tablet
  • Capsule
  • Suspension
  • Others
Companies covered
  • Xinhua Pharmaceutical
  • IOLCP
  • Granules Biocause
  • Strides Shasun
  • BASF
  • SI Group
  • Xinhua-Perrigo Pharmaceutical
  • Hisoar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ibuprofen Sales Value (2021-2032)
  4. 1.2.2 Global Ibuprofen Sales Volume (2021-2032)
  5. 1.2.3 Global Ibuprofen Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ibuprofen Market Dynamics
  1. 2.1 Ibuprofen Industry Trends
  2. 2.2 Ibuprofen Industry Drivers
  3. 2.3 Ibuprofen Industry Opportunities and Challenges
  4. 2.4 Ibuprofen Industry Restraints
3 Ibuprofen Market by Company
  1. 3.1 Global Ibuprofen Company Revenue Ranking in 2025
  2. 3.2 Global Ibuprofen Revenue by Company (2021-2026)
  3. 3.3 Global Ibuprofen Sales Volume by Company (2021-2026)
  4. 3.4 Global Ibuprofen Average Price by Company (2021-2026)
  5. 3.5 Global Ibuprofen Company Ranking (2024-2026)
  6. 3.6 Global Ibuprofen Company Manufacturing Base and Headquarters
  7. 3.7 Global Ibuprofen Company Product Type and Application
  8. 3.8 Global Ibuprofen Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ibuprofen Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ibuprofen Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ibuprofen Market by Type
  1. 4.1 Ibuprofen Type Introduction
  2. 4.1.1 USP
  3. 4.1.2 EP
  4. 4.2 Global Ibuprofen Sales Volume by Type
  5. 4.2.1 Global Ibuprofen Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ibuprofen Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ibuprofen Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ibuprofen Sales Value by Type
  9. 4.3.1 Global Ibuprofen Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ibuprofen Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ibuprofen Sales Value Share by Type (2021-2032)
5 Ibuprofen Market by Application
  1. 5.1 Ibuprofen Application Introduction
  2. 5.1.1 Tablet
  3. 5.1.2 Capsule
  4. 5.1.3 Suspension
  5. 5.1.4 Others
  6. 5.2 Global Ibuprofen Sales Volume by Application
  7. 5.2.1 Global Ibuprofen Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ibuprofen Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Ibuprofen Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Ibuprofen Sales Value by Application
  11. 5.3.1 Global Ibuprofen Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ibuprofen Sales Value by Application (2021-2032)
  13. 5.3.3 Global Ibuprofen Sales Value Share by Application (2021-2032)
6 Ibuprofen Regional Sales and Value Analysis
  1. 6.1 Global Ibuprofen Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ibuprofen Sales by Region (2021-2032)
  3. 6.2.1 Global Ibuprofen Sales by Region: 2021-2026
  4. 6.2.2 Global Ibuprofen Sales by Region (2027-2032)
  5. 6.3 Global Ibuprofen Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ibuprofen Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ibuprofen Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ibuprofen Sales Value by Region (2027-2032)
  9. 6.5 Global Ibuprofen Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ibuprofen Sales Value (2021-2032)
  12. 6.6.2 North America Ibuprofen Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ibuprofen Sales Value (2021-2032)
  15. 6.7.2 Europe Ibuprofen Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ibuprofen Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ibuprofen Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ibuprofen Sales Value (2021-2032)
  21. 6.9.2 South America Ibuprofen Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ibuprofen Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ibuprofen Sales Value Share by Country, 2025 VS 2032
7 Ibuprofen Country-level Sales and Value Analysis
  1. 7.1 Global Ibuprofen Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ibuprofen Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ibuprofen Sales by Country (2021-2032)
  4. 7.3.1 Global Ibuprofen Sales by Country (2021-2026)
  5. 7.3.2 Global Ibuprofen Sales by Country (2027-2032)
  6. 7.4 Global Ibuprofen Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ibuprofen Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ibuprofen Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ibuprofen Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ibuprofen Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ibuprofen Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ibuprofen Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ibuprofen Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ibuprofen Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ibuprofen Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ibuprofen Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ibuprofen Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ibuprofen Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ibuprofen Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ibuprofen Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ibuprofen Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ibuprofen Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ibuprofen Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ibuprofen Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ibuprofen Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ibuprofen Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ibuprofen Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ibuprofen Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ibuprofen Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ibuprofen Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ibuprofen Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ibuprofen Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ibuprofen Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ibuprofen Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ibuprofen Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ibuprofen Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ibuprofen Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ibuprofen Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ibuprofen Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ibuprofen Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ibuprofen Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ibuprofen Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ibuprofen Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ibuprofen Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ibuprofen Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ibuprofen Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ibuprofen Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ibuprofen Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ibuprofen Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ibuprofen Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ibuprofen Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ibuprofen Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ibuprofen Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ibuprofen Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ibuprofen Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ibuprofen Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ibuprofen Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ibuprofen Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ibuprofen Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ibuprofen Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ibuprofen Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ibuprofen Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ibuprofen Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ibuprofen Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ibuprofen Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ibuprofen Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ibuprofen Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ibuprofen Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ibuprofen Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ibuprofen Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ibuprofen Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ibuprofen Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ibuprofen Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ibuprofen Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ibuprofen Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ibuprofen Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ibuprofen Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ibuprofen Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ibuprofen Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ibuprofen Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ibuprofen Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ibuprofen Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ibuprofen Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ibuprofen Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ibuprofen Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ibuprofen Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ibuprofen Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ibuprofen Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ibuprofen Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ibuprofen Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ibuprofen Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ibuprofen Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xinhua Pharmaceutical
  2. 8.1.1 Xinhua Pharmaceutical Company Information
  3. 8.1.2 Xinhua Pharmaceutical Business Overview
  4. 8.1.3 Xinhua Pharmaceutical Ibuprofen Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xinhua Pharmaceutical Ibuprofen Product Portfolio
  6. 8.1.5 Xinhua Pharmaceutical Recent Developments
  7. 8.2 IOLCP
  8. 8.2.1 IOLCP Company Information
  9. 8.2.2 IOLCP Business Overview
  10. 8.2.3 IOLCP Ibuprofen Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 IOLCP Ibuprofen Product Portfolio
  12. 8.2.5 IOLCP Recent Developments
  13. 8.3 Granules Biocause
  14. 8.3.1 Granules Biocause Company Information
  15. 8.3.2 Granules Biocause Business Overview
  16. 8.3.3 Granules Biocause Ibuprofen Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Granules Biocause Ibuprofen Product Portfolio
  18. 8.3.5 Granules Biocause Recent Developments
  19. 8.4 Strides Shasun
  20. 8.4.1 Strides Shasun Company Information
  21. 8.4.2 Strides Shasun Business Overview
  22. 8.4.3 Strides Shasun Ibuprofen Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Strides Shasun Ibuprofen Product Portfolio
  24. 8.4.5 Strides Shasun Recent Developments
  25. 8.5 BASF
  26. 8.5.1 BASF Company Information
  27. 8.5.2 BASF Business Overview
  28. 8.5.3 BASF Ibuprofen Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BASF Ibuprofen Product Portfolio
  30. 8.5.5 BASF Recent Developments
  31. 8.6 SI Group
  32. 8.6.1 SI Group Company Information
  33. 8.6.2 SI Group Business Overview
  34. 8.6.3 SI Group Ibuprofen Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SI Group Ibuprofen Product Portfolio
  36. 8.6.5 SI Group Recent Developments
  37. 8.7 Xinhua-Perrigo Pharmaceutical
  38. 8.7.1 Xinhua-Perrigo Pharmaceutical Company Information
  39. 8.7.2 Xinhua-Perrigo Pharmaceutical Business Overview
  40. 8.7.3 Xinhua-Perrigo Pharmaceutical Ibuprofen Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Xinhua-Perrigo Pharmaceutical Ibuprofen Product Portfolio
  42. 8.7.5 Xinhua-Perrigo Pharmaceutical Recent Developments
  43. 8.8 Hisoar
  44. 8.8.1 Hisoar Company Information
  45. 8.8.2 Hisoar Business Overview
  46. 8.8.3 Hisoar Ibuprofen Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hisoar Ibuprofen Product Portfolio
  48. 8.8.5 Hisoar Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ibuprofen Value Chain Analysis
  2. 9.1.1 Ibuprofen Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ibuprofen Sales Mode & Process
  6. 9.2 Ibuprofen Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ibuprofen Distributors
  9. 9.2.3 Ibuprofen Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst